Engineering services company L&T Technology Services Limited (NSE: LTTS) announced on Monday that it has partnered with AI computing company NVIDIA to unveil Gen AI and advanced software-defined architecture for medical devices, focusing on endoscopy. The collaborative effort aims to address industry challenges related to custom hardware components, enhancing image quality and scalability for medical applications.
The scalable platform integrates a comprehensive image processing pipeline, incorporating noise reduction, edge and contrast enhancement, texture and color enhancement and speckle correction. Unique features include AI/ML models for polyp detection during colonoscopies.
Leveraging NVIDIA Holoscan and NVIDIA IGX Orin platforms, the architecture ensures low-latency data transfer, superior image processing and scalability for multiple AI-enabled applications, enhancing visualisation and decision-making support.
L&T Technology Services, a subsidiary of Larsen & Toubro Limited, specializes in Engineering and R&D services, serving Fortune 500 and top ER&D companies globally across various industries. With over 23,800 employees and a vast global presence, the collaboration emphasizes cutting-edge advancements in medical imaging technology.
Genedrive receives FDA Breakthrough Device Designation for infant hearing loss test
Mainz Biomed seeks FDA fast track for next-gen colorectal cancer test
Neuromod Devices names new general counsel
Delta-Fly Pharma initiates Phase III trial for lung cancer drug DFP-14323
Igraine plc investee Fixit Medical secures GBP270,000 Innovate UK grant
Pulnovo Medical enrols first two patients in PADN technology global multicentre clinical study
Getinge introduces CE-certified Pulsiocare for advanced hemodynamic monitoring
CND Life Sciences announces new appointments to leadership team
Tempus announces receipt of FDA clearance for AI-based AFib risk detection
bioMérieux receives FDA clearance for VITEK REVEAL AST System
CLS secures order from ClearPoint Neuro for North American launch
Bausch + Lomb to present new data at European Dry Eye Society 2024 Congress